178 related articles for article (PubMed ID: 34344472)
1. Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.
Lauk O; Patella M; Neuer T; Battilana B; Frauenfelder T; Nguyen-Kim TDL; Weder W; Caviezel C; Hillinger S; Inci I; Opitz I
Cancer Imaging; 2021 Aug; 21(1):48. PubMed ID: 34344472
[TBL] [Abstract][Full Text] [Related]
2. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.
Bölükbas S; Eberlein M; Kudelin N; Demes M; Stallmann S; Fisseler-Eckhoff A; Schirren J
Eur J Cardiothorac Surg; 2013 Jul; 44(1):119-23. PubMed ID: 23242984
[TBL] [Abstract][Full Text] [Related]
4. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
6. FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.
Incerti E; Broggi S; Fodor A; Cuzzocrea M; Samanes Gajate AM; Mapelli P; Fiorino C; Dell'Oca I; Pasetti M; Cattaneo M; Calandrino R; Gianolli L; Di Muzio N; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2071-2078. PubMed ID: 29876617
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Rusch VW; Gill R; Mitchell A; Naidich D; Rice DC; Pass HI; Kindler HL; De Perrot M; Friedberg J;
Ann Thorac Surg; 2016 Oct; 102(4):1059-66. PubMed ID: 27596916
[TBL] [Abstract][Full Text] [Related]
8. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pretreatment volume-based quantitative
Kitajima K; Doi H; Kuribayashi K; Hashimoto M; Tsuchitani T; Tanooka M; Fukushima K; Nakano T; Hasegawa S; Hirota S
Eur J Radiol; 2017 Jan; 86():176-183. PubMed ID: 28027744
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening.
Nakamura A; Hashimoto M; Kodama H; Yuki M; Kondo N; Yamakado K; Tsujimura T; Kijima T; Hasegawa S
Int J Clin Oncol; 2021 Jan; 26(1):95-103. PubMed ID: 32914367
[TBL] [Abstract][Full Text] [Related]
11. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
[TBL] [Abstract][Full Text] [Related]
12. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
13. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
14. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.
Liu F; Zhao B; Krug LM; Ishill NM; Lim RC; Guo P; Gorski M; Flores R; Moskowitz CS; Rusch VW; Schwartz LH
J Thorac Oncol; 2010 Jun; 5(6):879-84. PubMed ID: 20421814
[TBL] [Abstract][Full Text] [Related]
15. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
Gill RR; Naidich DP; Mitchell A; Ginsberg M; Erasmus J; Armato SG; Straus C; Katz S; Patios D; Richards WG; Rusch VW;
J Thorac Oncol; 2016 Aug; 11(8):1335-1344. PubMed ID: 27180318
[TBL] [Abstract][Full Text] [Related]
16. Induction Therapy for Mesothelioma.
Opitz I; Weder W
Semin Thorac Cardiovasc Surg; 2015; 27(2):240-9. PubMed ID: 26686455
[TBL] [Abstract][Full Text] [Related]
17. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
Nakamura A; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Matsumoto S; Kondo N; Kijima T; Yamakado K; Hasegawa S
Ann Thorac Surg; 2020 May; 109(5):1537-1543. PubMed ID: 31962118
[TBL] [Abstract][Full Text] [Related]
19. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
Armato SG; Labby ZE; Coolen J; Klabatsa A; Feigen M; Persigehl T; Gill RR
Lung Cancer; 2013 Nov; 82(2):190-6. PubMed ID: 24018024
[TBL] [Abstract][Full Text] [Related]
20. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
